Odink Debra

Avg. Two Year Performance

(74%) Avg. Purchase Return
(32%) Compound
95% Avg. Sale Return
40% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return62%19%53%16%(74%)
Purchase Success Rate1 of 11 of 11 of 11 of 10 of 1
Average Sale Return19%67%79%84%95%
Sale Success Rate3 of 44 of 44 of 44 of 44 of 4
Drugs » Drug Manufacturers - Major

Chief Technology Officer:

Holdings: 21.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--